NEWS
View news from our Featured Companies.
LiqTech Receives First Middle East Oil and Gas Order and Schedules Business Update Conference Call
Company to Host Conference Call on Thursday, October 7, 2021 at 8:30am ET with Details Included BelowBALLERUP, Denmark, Oct. 6, 2021 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021
PORTLAND, Maine, Oct. 06, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
S&W to Participate in Panel Discussion “Food Security and the Agricultural Supply Chain” at the Lytham Partners Fall 2021 Investor Conference
Panel discussion scheduled for 11:00am ET on Wednesday, October 6, 2021LONGMONT, Colo., Oct. 4, 2021 -- S&W Seed Company (Nasdaq: SANW) today announced that the Company's CEO, Mark Wong, will be participating in a panel at the Lytham Partners Fall 2021 Investor...
INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
SARASOTA, Fla., Oct. 1, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, today announced that it has entered into definitive agreements with institutional...
ChromaDex Comments on Jury Award Against Elysium Health and Reiterates Plans for Growth
Elysium Health to pay ChromaDex approximately $2.25 to $2.50 million in damages plus interest for breach of contract New partnership with Sinopharm Xingsha and recent partnerships with Walmart, H&H Group, and Ro to support next phase of growth LOS ANGELES -...
SenesTech to Present at the Lytham Partners Fall 2021 Investor Conference
PHOENIX, Sept. 30, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday,...
Arianne Phosphate Announces Election Results of Its 2021 Annual General Meeting
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, Sept. 30, 2021 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
CORRECTION: Aytu BioPharma to Present at Upcoming September Investor Conferences
(This release corrects the previous one that was issued on September 7, 2021 to reflect the time of the Cantor Presentation being changed to 2:40 pm EST)ENGLEWOOD, CO / September 30, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused...
Scientific Industries to Present at the Lytham Partners Fall 2021 Investor Conference
BOHEMIA, NY and PITTSBURGH, PA / September 29, 2021 / Scientific Industries, Inc. (OTCQB:SCND) announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Tuesday, October 5, 2021 at 4:15 PM ET.A webcast of the presentation will be...
Arianne Phosphate to Attend the Lytham Partners Fall 2021 Investor Conference
DAN: TSX-V (Canada) JE9N: FSE (Germany) DRRSF: OTC (USA) SAGUENAY, QC, Sept. 29, 2021 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
ChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland China
LOS ANGELES - ChromaDex Corp. (NASDAQ: CDXC) announced today a partnership with Sinopharm Xingsha Pharmaceuticals (Xiamen) Co., Ltd. ("Sinopharm Xingsha") to conduct cross-border sales of Tru Niagen® in mainland China. Sinopharm Xingsha is a subsidiary of...
Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial Results
Quarterly net revenue increased 74% sequentially to $23.5M; 138% year-over-year to $65.6MEnded quarter with approximately $50M in cash, cash equivalents and restricted cashPlanned pivotal study for AR101 in Vascular Ehlers-Danlos Syndrome (VEDS) to begin in 1H22;...
S&W Announces Fiscal 2021 Financial Results
Conference call to be conducted on Monday, September 27, 2021 at 11:00 am ETLONGMONT, Colo., Sept. 27, 2021 -- S&W Seed Company (Nasdaq: SANW) today announced financial results for fiscal year 2021 ended June 30, 2021. The Company had announced preliminary fiscal...
Aytu BioPharma to Report Fourth Quarter and Full Year Fiscal 2021 Results and Provide Business Update on September 27, 2021
ENGLEWOOD, CO / September 23, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that it will host a conference call and live webcast on...
S&W Seed Company to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Monday, September 27, 2021
Conference call to be conducted on Monday, September 27, 2021 at 11:00AM ETLONGMONT, Colo., Sept. 21, 2021 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its fourth quarter and fiscal year 2021, ended June 30, 2021, on Monday, September 27,...
Greenfire Acquisition Corporation Closes Strategic Acquisition of JACOS and Announces Name Change to Greenfire Resources Operating Corporation
CALGARY, Canada - Greenfire Acquisition Corporation ("GAC" or the "Company") announces the successful closing of the strategic acquisition of Japan Canada Oil Sands Limited ("JACOS"), which includes a 75% working interest and operatorship of the Hangingstone Expansion...
PolyPid to Present at Upcoming Cantor Fitzgerald Global Healthcare Conference
PETAH TIKVA, Israel, Sept. 20, 2021 -- PolyPid Ltd. (Nasdaq: PYPD), a phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, today announced its participation in...
ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP™)
New preclinical data from the ChromaDex External Research Program (CERP) shows positive effects of nicotinamide riboside (NR) in glaucoma, Alzheimer's disease, and cardiac ischemia-reperfusion injury mouse models LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today...
Zoomd Technologies Enters Into New Publisher Agreements
Zoomd continues to enrich the company's publishers portfolio, onboarding new global media houses from Brazil, Turkey and Greece, adding millions of new page views and data points for monetization ahead of Q4 2021 VANCOUVER, BC, Sept. 17, 2021 /CNW/ -- Zoomd...
Mogo to Participate in BTIG Future of Digital Assets Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced that Greg Feller, President, will be participating in the BTIG Future of Digital Assets Conference on...
Reviva Pharmaceuticals to Present at the Upcoming Benzinga Healthcare Small Cap Conference
CUPERTINO, Calif., Sept. 15, 2021 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
ChromaDex Continues to Defend Strong Intellectual Property Portfolio and Plans to Appeal Judge’s Ruling in Patent Infringement Lawsuit
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) issued the following statement: ChromaDex announced today plans to appeal a September 14 decision granting a Motion for Summary Judgment (MSJ) in its lawsuit for patent infringement against Elysium Health, Inc. ("Elysium")...
Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team
PORTLAND, Maine, Sept. 14, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Positive Results in Two Animal Models of Glioblastoma Multiform (GBM) demonstrated that Single Local Treatment of OncoPLEX Significantly Inhibited Tumor Growth and Prolonged SurvivalCompany Expects a Pre-IND Meeting with the U.S. FDA by Year End and Potential...
Ingredion and S&W Enter US Stevia Pilot Production Supply Agreement
Exclusive Agreement Enables Opportunity to Scale US Stevia SupplyWESTCHESTER, Ill. and LONGMONT, Colo., Sept. 9, 2021 -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, and S&W...